Published in Korean J Anesthesiol on May 26, 2017
The pathophysiology and treatment of sepsis. N Engl J Med (2003) 21.67
Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med (2008) 11.00
On the Physiological Action of Extracts of Pituitary Body and certain other Glandular Organs: Preliminary Communication. J Physiol (1895) 6.35
A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med (2004) 6.04
Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation (2010) 5.89
Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation (1997) 4.54
Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet (2001) 4.31
The pathogenesis of vasodilatory shock. N Engl J Med (2001) 2.94
Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. N Engl J Med (2008) 2.72
Part 12: cardiac arrest in special situations: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation (2010) 2.64
The vasopressin system: physiology and clinical strategies. Anesthesiology (2006) 2.62
Circulating vasopressin levels in septic shock. Crit Care Med (2003) 2.22
Physiology of vasopressin relevant to management of septic shock. Chest (2001) 2.17
Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City, Va. Circulation (2002) 2.14
Vasopressin: behavioral roles of an "original" neuropeptide. Prog Neurobiol (2007) 2.04
Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg (1998) 1.95
The pivotal role of vasopressin in refractory anaphylactic shock. Anesth Analg (2008) 1.77
Role of vasopressin in the management of septic shock. Intensive Care Med (2004) 1.74
Vasopressin receptor antagonists. Kidney Int (2006) 1.72
Part 7: Adult Advanced Cardiovascular Life Support: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation (2015) 1.71
Epinephrine increases the severity of postresuscitation myocardial dysfunction. Circulation (1995) 1.68
Bradycardia and cardiac arrest caused by intramyometrial injection of vasopressin during a laparoscopically assisted myomectomy. Obstet Gynecol (2009) 1.66
Employing vasopressin as an adjunct vasopressor in uncontrolled traumatic hemorrhagic shock. Three cases and a brief analysis of the literature. Anaesthesist (2005) 1.66
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med (2017) 1.54
Vasopressin, but not fluid resuscitation, enhances survival in a liver trauma model with uncontrolled and otherwise lethal hemorrhagic shock in pigs. Anesthesiology (2003) 1.53
Plasma vasopressin response to hypertonic saline infusion to assess posterior pituitary function. J R Soc Med (1980) 1.50
The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med (2001) 1.43
Human vascular endothelial cells express oxytocin receptors. Endocrinology (1999) 1.40
Intraoperative myocardial infarction after paracervical vasopressin infiltration. Anesth Analg (1994) 1.38
The effects of vasopressin on acute kidney injury in septic shock. Intensive Care Med (2009) 1.34
Vasopressin improves vital organ blood flow during closed-chest cardiopulmonary resuscitation in pigs. Circulation (1995) 1.32
Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med (2007) 1.28
Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction. Anesthesiology (1994) 1.26
Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med (1997) 1.24
Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial. JAMA (2016) 1.23
Vasopressin for treatment of vasodilatory shock: an ESICM systematic review and meta-analysis. Intensive Care Med (2011) 1.22
Structural bases of vasopressin/oxytocin receptor function. J Endocrinol (1998) 1.22
Renal microvascular effects of vasopressin and vasopressin antagonists. Am J Physiol (1989) 1.20
A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation (1997) 1.20
Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study. Crit Care (2009) 1.20
Hormonal therapy of the brain-dead organ donor: experimental and clinical studies. Transplantation (2006) 1.17
Pharmacology and clinical perspectives of vasopressin antagonists. Pharmacol Rev (1991) 1.13
Desmopressin (DDAVP) in the treatment of bleeding disorders: the first twenty years. Haemophilia (2000) 1.11
Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery. Circulation (1999) 1.09
Systematic review: terlipressin in acute oesophageal variceal haemorrhage. Aliment Pharmacol Ther (2003) 1.09
Cardiac performance during vasopressin infusion in postcardiotomy shock. Intensive Care Med (2002) 1.07
A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass. Ann Thorac Surg (2003) 1.03
Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors. Circulation (1999) 1.01
Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock. Circulation (1999) 1.01
Release of endogenous vasopressors during and after cardiopulmonary resuscitation. Heart (1996) 0.99
Survival with full neurologic recovery after prolonged cardiopulmonary resuscitation with a combination of vasopressin and epinephrine in pigs. Anesth Analg (2003) 0.97
Pressor effect of arginine vasopressin in progressive autonomic failure. Clin Sci (Lond) (1986) 0.97
Vasopressin vs norepinephrine in endotoxic shock: systemic, renal, and splanchnic hemodynamic and oxygen transport effects. J Appl Physiol (1985) (2003) 0.96
Survival with full neurologic recovery and no cerebral pathology after prolonged cardiopulmonary resuscitation with vasopressin in pigs. J Am Coll Cardiol (2000) 0.95
Cardiovascular management of a potential heart donor: a statement from the Transplantation Committee of the American College of Cardiology. Crit Care Med (1996) 0.94
Perioperative management of pheochromocytoma: focus on magnesium, clevidipine, and vasopressin. J Cardiothorac Vasc Anesth (2012) 0.94
Randomised comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation. Lancet (1997) 0.93
Terlipressin versus norepinephrine to counteract anesthesia-induced hypotension in patients treated with renin-angiotensin system inhibitors: effects on systemic and regional hemodynamics. Anesthesiology (2005) 0.93
Vasopressin-induced nitric oxide production in rat inner medullary collecting duct is dependent on V2 receptor activation of the phosphoinositide pathway. Am J Physiol Renal Physiol (2007) 0.92
Central nervous system mediators of vasopressin release. Physiol Rev (1983) 0.90
Comparative effects of vasopressin, norepinephrine, and L-canavanine, a selective inhibitor of inducible nitric oxide synthase, in endotoxic shock. Am J Physiol Heart Circ Physiol (2004) 0.89
The pore-forming subunit of the K(ATP) channel is an important molecular target for LPS-induced vascular hyporeactivity in vitro. Br J Pharmacol (2005) 0.87
Novel agents for the treatment of hyponatremia: a review of conivaptan and tolvaptan. Cardiol Rev (2010) 0.87
Area postrema and sympathetic nervous system effects of vasopressin and angiotensin II. Clin Exp Pharmacol Physiol (2000) 0.87
Under general anesthesia arginine vasopressin prevents hypotension but impairs cerebral oxygenation during arthroscopic shoulder surgery in the beach chair position. Anesth Analg (2013) 0.86
Pharmacologic manipulation of the peripheral vasculature in shock: clinical and experimental approaches. Circ Shock (1986) 0.85
Vasopressin for cardiac arrest: meta-analysis of randomized controlled trials. Resuscitation (2011) 0.85
Sympathetic neural blockade by thoracic epidural anesthesia suppresses renin release in response to arterial hypotension. Anesthesiology (1994) 0.84
Endogenous vasopressin and renin-angiotensin systems support blood pressure after epidural block in humans. Anesthesiology (1994) 0.84
Evaluation of cardiac output, total peripheral vascular resistance, and plasma concentrations of vasopressin in the conscious, unrestrained rat during endotoxemia. Circ Shock (1985) 0.84
Arginine vasopressin in the management of vasodilatory hypotension after cardiac transplantation. J Heart Lung Transplant (1999) 0.83
Pharmacokinetics of terlipressin after single i.v. doses to healthy volunteers. Drugs Exp Clin Res (1990) 0.83
Terlipressin for treating intraoperative hypotension: can it unmask myocardial ischemia? Anesth Analg (2001) 0.83
Mortality benefit of vasopressor and inotropic agents in septic shock: a Bayesian network meta-analysis of randomized controlled trials. J Crit Care (2014) 0.82
Successful resuscitation of a traumatic cardiac arrest victim in hemorrhagic shock with vasopressin: a case report and brief review of the literature. J Trauma (2004) 0.82
Vasodilation induced by vasopressin V2 receptor stimulation in afferent arterioles. Kidney Int (1996) 0.82
Comparison of responses of canine pulmonary artery and vein to angiotensin II, bradykinin and vasopressin. Eur J Pharmacol (1995) 0.81
Vasopressin in hemorrhagic shock: review article. Am Surg (2009) 0.81
Vasopressin in hemorrhagic shock: a systematic review and meta-analysis of randomized animal trials. Biomed Res Int (2014) 0.81
Plasma vasopressin levels and urinary sodium excretion during cardiopulmonary bypass with and without pulsatile flow. Ann Thorac Surg (1981) 0.81
Does treatment of cadaveric organ donors with desmopressin increase the likelihood of pancreas graft thrombosis? Results of a preliminary study. Transplant Proc (2004) 0.80
Vasopressin versus Norepinephrine in Patients with Vasoplegic Shock After Cardiac Surgery: The VANCS Randomized Controlled Trial. Anesthesiology (2016) 0.79
The effect of moderate hypotension on vasopressin levels in normal humans. Am J Med Sci (1989) 0.79
Pressors for cardiopulmonary resuscitation: is there a new kid on the block? Crit Care Med (2000) 0.79
Vasopressin mediated vasodilation of cerebral arteries. J Auton Nerv Syst (1994) 0.78
Effect of arginine vasopressin on the canine epicardial coronary artery: experiments on V1-receptor-mediated production of nitric oxide. Arq Bras Cardiol (2003) 0.78
Morphological and functional alterations of the hypothalamic-pituitary system in brain death with long-term bodily living. Acta Neurochir (Wien) (1992) 0.77
Vasopressin: a review of therapeutic applications. J Cardiothorac Vasc Anesth (2009) 0.77
A century of arginine vasopressin research leading to new therapeutic strategies. Anesthesiology (2006) 0.77
Arginine vasopressin (AVP): a review of its historical perspectives, current research and multifunctional role in the hypothalamo-hypophysial system. Pituitary (2016) 0.76
The role of vasopressin and the vasopressin type V1a receptor agonist selepressin in septic shock. J Crit Care (2017) 0.76
Treatment of hyponatremia: the role of lixivaptan. Expert Rev Clin Pharmacol (2014) 0.76
Splanchnic and renal blood flow after cardiopulmonary resuscitation with epinephrine and vasopressin in pigs. Resuscitation (1998) 0.76
Long-term renal preservation after brain death maintained with vasopressin and epinephrine. Transpl Int (1990) 0.76
Withholding versus Continuing Angiotensin-converting Enzyme Inhibitors or Angiotensin II Receptor Blockers before Noncardiac Surgery: An Analysis of the Vascular events In noncardiac Surgery patIents cOhort evaluatioN Prospective Cohort. Anesthesiology (2016) 0.76
Review of clinical experience of desmopressin in patients with congenital and acquired bleeding disorders. Eur J Anaesthesiol Suppl (1997) 0.76
Intra-operative activation of coagulation--a stimulus to thrombosis mediated by vasopressin? Thromb Haemost (1986) 0.76
Effects of intravenously administered indocyanine green on near-infrared cerebral oximetry and pulse oximetry readings. Korean J Anesthesiol (2015) 0.82
Intrathecal Morphine Infusion Therapy in Management of Chronic Pain: Present and Future Implementation in Korea. Yonsei Med J (2016) 0.75